ProQR Therapeutics (PRQR) Return on Sales Growth (1y) (2014 - 2026)

ProQR Therapeutics (PRQR) Return on Sales Growth (1y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (1y) (Qtr)
1 Oculis Holding AG 67,102.16 Bn 67,101.87 Bn - -
2 Nanobiotix 1,913.50 Bn 1,913.44 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 472.39 Bn 467.60 Bn 1.35 Bn 0.00
5 Vertex Pharmaceuticals 122.08 Bn 114.83 Bn 2.59 Bn 0.00
6 Regeneron Pharmaceuticals 69.98 Bn 61.22 Bn 3.31 Bn 0.00
7 Belite Bio 62.34 Bn 62.34 Bn - -
8 Argenx Se 55.97 Bn 50.78 Bn 1.41 Bn 0.00
9 Alnylam Pharmaceuticals 37.47 Bn 34.46 Bn 959.66 Mn 0.00
10 ProQR Therapeutics 184.91 Mn 92.62 Mn - -4.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.00
Dec 31, 2025 0.00
Sep 30, 2025 -2.00
Jun 30, 2025 -3.00
Mar 31, 2025 -1.00
Dec 31, 2024 0.00
Sep 30, 2024 2.00
Jun 30, 2024 6.00
Mar 31, 2024 12.00
Dec 31, 2023 17.00
Sep 30, 2023 25.00
Jun 30, 2023 8.00
Mar 31, 2023 -1.00
Dec 31, 2022 57.00
Sep 30, 2022 -11.00
Jun 30, 2022 50.00
Mar 31, 2022 -11.00
Dec 31, 2021 -75.00
Sep 30, 2021 -16.00
Jun 30, 2021 -63.00